CCompany · Healthtech & Bio
Celtarys Research
Celtarys Research is a biotech company spun out of the University of Santiago de Compostela in 2021 that develops and commercializes fluorescent chemical tools (ligands, biotinylated probes) used to replace radioactive methods in high-throughput screening and drug discovery, focused on GPCRs, E3 ligases and intracellular receptors. It positions itself as the only company exclusively dedicated to fluorescent probes replacing radioactivity, and works with 40+ clients in 14 countries. It is headquartered in Santiago de Compostela, Galicia.
Founded
2021
Founders
8
News
0
Rounds
1
Investors
2
SectorsBiotech, Drug Discovery Tools, Chemical Biology
Start-up MapHealthtech & Bio › R&D tools & software for life sciences
Profile updated 29 Jul 2026
Founders
E
Eddy Sotelo
Co-founder & Chairman of the Board
J
Javier Sardina
Co-founder
—
J
Jhonny Azuaje
Co-founder
J
Jose Brea (Pepo Brea)
Co-founder
J
Jose Manuel Santamaría Pérez
Co-founder / Board Member
M
Mabel Loza
Co-founder
—
M
Maria Majellaro
Co-founder & Chief Scientific Officer
S
Sonia Martínez Arca
Co-founder (former CEO)
Global models 5
TTwist Bioscience
United States · www.twistbioscience.com ↗
A life-science tools company that commercializes proprietary synthesis technology as reagents/kits for biopharma R&D, similar to Celtarys selling proprietary chemical-tool kits into drug discovery workflows.
$291MComparable
110x Genomics
United States · www.10xgenomics.com ↗
An academic-spinout life-science tools company selling proprietary reagent/instrument kits that enable biological research and drug discovery, the same reagents-for-research-labs business model as Celtarys.
$277MComparable
BBerkeley Lights (PhenomeX)
United States · www.bruker.com ↗
A life-science tools company providing cell-based screening technology to pharma/biotech customers for drug discovery, comparable to Celtarys' assay/screening tools for HTS.
$152MComparable
MMission Bio
United States · missionbio.com ↗
An academic-adjacent life-science tools company selling a proprietary single-cell analysis platform/reagents into pharma R&D, the same tools-for-drug-discovery model as Celtarys.
$120MComparable
NNautilus Biotechnology
United States · www.nautilus.bio ↗
A life-science tools startup commercializing a novel proprietary biomolecular detection platform for research/drug discovery customers, comparable in model to Celtarys' proprietary probe technology.
$109MComparable
Investors 2
Funding rounds 1
News & media
No coverage on record yet.

